Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 928 results for "cipla india"

Sensex snaps losing streak, spurts 352 points

Infosys falls 2%, ONGC Cipla up; Sensex, Nifty flat

9:50 am Buzzing: Shares of Jubilant FoodWorks rallied as much as 3.4 percent intraday after the Reserve Bank of India has increased FII investment limit in the company. "The Reserve Bank of India on Tuesday notified that foreign institutional ..., 5 days ago
FIIs up stakes in 16 Sensex cos in Jan-March quarter Business Standard India, 3 days ago

59 images for cipla india, 1 week ago, 3 weeks ago, 1 week ago, 3 weeks ago, 2 months ago
MedIndia, 1 month ago
Financial Express, 2 months ago, 1 month ago, 2 months ago, 1 month ago

Sensex retreats after positive start; Cipla, Coal India decline on weak results

After opening on a positive note, the Indian stock market retreated and slipped into the red this morning, with weak December industrial output data weighing on sentiment. Metal, oil, power and bank stocks are a bit weak. Information technology, healthcare ...
 Sify2 months ago Sensex down 123 points as stocks reel under selling pressure  Sify2 weeks ago

Sensex falls 129 points; JSPL, BHEL, Cipla drag

Indian equities still trading in the negative terrain on Monday. Realty, consumer durables, power and capital goods stocks witnessed a fall. At 2.22 p.m., the Sensex was trading down 129.15 points or 0.58% at 22,230.35 with 23 components falling.
 MyIris2 weeks ago

Nifty falls below 6,050; Cipla, BoB, Coal India down

The Nifty extended its intraday losses and fell below 6,050 level as institutional investors resumed profit booking in index heavyweights. MUMBAI: The Nifty extended its intraday losses and fell below 6,050 level as institutional investors resumed profit ...
 Economic Times2 months ago Sensex loses 150 pts, Nifty ends below 6700; Cipla, SBI up  Moneycontrol.com2 weeks ago Sensex cracks 208 pts, Nifty ends below 6700; IT bleeds  Moneycontrol.com5 days ago Nifty struggles at 6700; IndusInd Bank Q4 net profit up 29%  Moneycontrol.com5 days ago

BSE Sensex falls 255 points; Cipla slumps

The BSE Sensex fell 1.3 percent on Thursday to post its second-biggest drop this month as Cipla and Coal India slumped following disappointing earnings, while other blue chips tracked their lower global counterparts. Cipla Ltd slumped nearly 8 percent, while ...
 Sify2 months ago Sensex down 255 points, biggest fall in 10 days  The Hindu2 months ago Sensex down 255 pts, drops most in 10 days; CIL, Cipla tank  Business Standard2 months ago Sensex end 255 points down; CIL, Cipla tank  Times of India2 months ago

Cipla, Coal India in focus after declaring Q3 results

Cipla's consolidated net profit fell 17% to Rs 284 crore on 22% rise in income from operations to Rs 2581 crore in Q3 December 2013 over Q3 December 2012. The result was announced after market hours on Wednesday, 12 February 2014. Coal India's consolidated ...
 Business Standard2 months ago Cipla head donates Rs 8 crore to promote chemistry education in India  First Post.com2 months ago Cipla chairman donates Rs 8 cr to promote chemistry  Deccan Herald2 months ago Cipla head donates Rs.8 crore to promote chemistry in India  Prokerala2 months ago
Med India

Merck to have Cipla make cut-rate version of an HIV drug

FierceBiotech file photo India 's Cipla has been aggressive about taking aim at Western meds it thinks are too expensive for the Indian market, sometimes targeting those that have seen their patents pushed aside by compulsory licenses. But ...
 FiercePharma1 month ago Cipla to Market MSD's Raltegravir in India  Med India1 month ago MSD, Cipla to co-market AIDS drug in India  The Hindu1 month ago Cipla to sell MSDs HIV drug in India  Business Line1 month ago

Cipla bets big on cell therapy

In India, stem cell biz may touch $8 b by 2015 Mumbai, March 21: Stem cells are set to be a major branch of medical treatment, says Cipla Chairman YK Hamied. Regenerative medicine, or cell therapy, is a rapidly emerging area of biomedical research and would ...
 Business Line1 month ago CIPLA : Bets big on cell therapy  4 Traders4 weeks ago

CIPLA : Merck hiv drug strategy seen shielding patent

03/24/2014 | 08:40am US/Eastern Recommend: Merck is planning to launch HIV drug in India in partnership with Cipla Ltd in Jun 2014 . The partnership is likely to protect its patent as India seeks cheaper generics. Merck is likely ...
 4 Traders4 weeks ago Merck signposts a new strategy for patent owners in India  Intellectual Asset Management3 weeks ago Merck's India HIV Drug Strategy May Shield Patent  Bloomberg1 month ago Merck & Co., Inc. HIV Drug Strategy Seen Shielding Patent  BioSpace1 month ago
Money Control

Stocks in news: Maruti, Crompton, Tech Mah, Bharti, LT Fin

AstraZeneca Pharma | IOC | Cipla | JSW Energy | Oil India | Crompton Greaves | Tech Mahindra | Bharti Airtel | Tata Power | Mastek | Mphasis | HSIL | Ashok Leyland | Tata Motors | LT Finance Holdings | Maruti Suzuki | Financial Technologies and MCX are ...
 Money Control1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less